Ibrutinib plus venetoclax is active in mantle cell lymphomaMarch 28, 2018Mantle Cell LymphomaAggressive Lymphomas
CAR T before transplant yields durable remission in B-cell malignanciesMarch 14, 2018Cellular TherapyAggressive Lymphomas
Outpatient CAR T infusions feasible using liso-celMarch 12, 2018Aggressive LymphomasCellular TherapyMantle Cell Lymphoma
Immunotherapy regimen influences inflammatory arthritis presentationMarch 5, 2018Patient & Survivor CareAggressive Lymphomas
Acalabrutinib shows less off-target activity in mantle cell lymphomaMarch 2, 2018Mantle Cell LymphomaAggressive Lymphomas
High objective response rate, OS seen with ATA129 in PTLDFebruary 24, 2018Aggressive LymphomasIndolent Lymphoma
Basiliximab/BEAM may improve post-ASCT outcomes in PTCLFebruary 21, 2018T Cell LymphomasAggressive Lymphomas
NF-kappaB pathway could help solve resistance problem in mantle cell lymphomaFebruary 16, 2018Mantle Cell LymphomaAggressive Lymphomas
Getting hematologic cancer drugs on the fast trackFebruary 9, 2018T Cell LymphomasAggressive Lymphomas
